Literature DB >> 33867627

Advances in management of end stage liver disease in children.

Aradhana Aneja1, Elizabeth Scott2, Rohit Kohli3.   

Abstract

End stage liver disease (ESLD) is an irreversible condition that is a management challenge to the paediatrician. The aetiology and natural history of ESLD in children is not only distinct from adults but also variable depending upon the age of presentation. Children are especially vulnerable to developmental delay, frailty and malnutrition. Nutritional support is the cornerstone of management of these children as it has a significant impact on the clinical course and survival, both before and after transplantation. Further, the complications of ESLD in children including but not limited to, ascites, portal hypertension, spontaneous bacterial peritonitis and encephalopathy raise unique management challenges. In this review we provide a concise review of and highlight recent advances in the management of paediatric ESLD.
© 2021 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Entities:  

Keywords:  Liver failure; Liver injury; Nutrition; Pediatrics; Transplant

Year:  2021        PMID: 33867627      PMCID: PMC8042505          DOI: 10.1016/j.mjafi.2021.03.001

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  57 in total

Review 1.  Indications for pediatric liver transplantation.

Authors:  S V McDiarmid; M J Millis; K M Olthoff; S K So
Journal:  Pediatr Transplant       Date:  1998-05

2.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

3.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2018-04-10       Impact factor: 25.083

Review 4.  Management of acute-on-chronic liver failure: an algorithmic approach.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Hepatol Int       Date:  2018-08-16       Impact factor: 6.047

5.  Pediatric gastroesophageal varices: treatment strategy and long-term results.

Authors:  Tetsuya Mitsunaga; Hideo Yoshida; Katsunori Kouchi; Tomoro Hishiki; Takeshi Saito; Shin-ichi Yamada; Yoshiharu Sato; Keita Terui; Mitsuyuki Nakata; Ayako Takenouchi; Naomi Ohnuma
Journal:  J Pediatr Surg       Date:  2006-12       Impact factor: 2.545

6.  A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.

Authors:  Barjesh Chander Sharma; Praveen Sharma; Manish Kumar Lunia; Siddharth Srivastava; Rohit Goyal; S K Sarin
Journal:  Am J Gastroenterol       Date:  2013-07-23       Impact factor: 10.864

Review 7.  Evaluation and management of end-stage liver disease in children.

Authors:  Mike A Leonis; William F Balistreri
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

8.  Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis.

Authors:  Dong Wu; Shu-Mei Wu; Jie Lu; Ying-Qun Zhou; Ling Xu; Chuan-Yong Guo
Journal:  Gastroenterol Res Pract       Date:  2013-04-03       Impact factor: 2.260

Review 9.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

10.  Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome.

Authors:  Benjamin L Shneider; Cathie Spino; Binita M Kamath; John C Magee; Lee M Bass; Kenneth D Setchell; Alexander Miethke; Jean P Molleston; Cara L Mack; Robert H Squires; Karen F Murray; Kathleen M Loomes; Philip Rosenthal; Saul J Karpen; Daniel H Leung; Stephen L Guthery; Danny Thomas; Averell H Sherker; Ronald J Sokol
Journal:  Hepatol Commun       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.